Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

Completed

Conditions studied: Metastatic Breast Cancer

In brief

This study evaluates the performance of a blood test for detecting biomarkers in metastatic breast cancer patients at one clinic against standard testing.

Key facts

Study ID

NCT02436772

Run by

SCRI Development Innovations, LLC

People needed

74

Starts

2015-05-13

Expected to finish

2017-07-07

Last updated by the study team

2020-09-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current patient at participating clinic
• Metastatic breast cancer diagnosis
• 18 years of age or older

You may not qualify if…

• None

Where it is running

• Tennessee Oncology — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.